AlphaQuest LLC Has $255,000 Position in Acadia Healthcare Company, Inc. $ACHC

AlphaQuest LLC grew its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 57.4% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,238 shares of the company’s stock after acquiring an additional 4,096 shares during the period. AlphaQuest LLC’s holdings in Acadia Healthcare were worth $255,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Caitong International Asset Management Co. Ltd increased its position in Acadia Healthcare by 11,218.2% during the first quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company’s stock worth $38,000 after buying an additional 1,234 shares during the last quarter. CWM LLC boosted its position in Acadia Healthcare by 105.1% during the second quarter. CWM LLC now owns 2,633 shares of the company’s stock worth $60,000 after purchasing an additional 1,349 shares during the period. Covestor Ltd increased its holdings in shares of Acadia Healthcare by 56.0% in the first quarter. Covestor Ltd now owns 2,262 shares of the company’s stock valued at $69,000 after purchasing an additional 812 shares during the last quarter. Signaturefd LLC raised its position in shares of Acadia Healthcare by 1,451.7% in the second quarter. Signaturefd LLC now owns 5,043 shares of the company’s stock valued at $114,000 after purchasing an additional 4,718 shares during the period. Finally, Parallel Advisors LLC lifted its stake in shares of Acadia Healthcare by 1,120.3% during the 2nd quarter. Parallel Advisors LLC now owns 5,174 shares of the company’s stock worth $117,000 after buying an additional 4,750 shares during the last quarter.

Acadia Healthcare Trading Down 1.4%

Shares of Acadia Healthcare stock opened at $21.50 on Friday. The firm’s 50-day moving average price is $23.52 and its two-hundred day moving average price is $22.87. The company has a market capitalization of $1.99 billion, a price-to-earnings ratio of 14.24, a PEG ratio of 4.56 and a beta of 0.90. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.73. Acadia Healthcare Company, Inc. has a 12-month low of $17.13 and a 12-month high of $47.08.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share for the quarter, topping analysts’ consensus estimates of $0.71 by $0.12. The company had revenue of $869.23 million during the quarter, compared to the consensus estimate of $839.59 million. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The firm’s quarterly revenue was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.91 EPS. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. On average, analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Analyst Ratings Changes

ACHC has been the topic of several research analyst reports. Cowen reissued a “buy” rating on shares of Acadia Healthcare in a report on Thursday, August 7th. Wall Street Zen upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Sunday, August 3rd. UBS Group reduced their price target on Acadia Healthcare from $45.00 to $31.00 and set a “buy” rating for the company in a research note on Thursday, August 7th. Mizuho decreased their price objective on Acadia Healthcare from $32.00 to $22.00 and set a “neutral” rating on the stock in a report on Wednesday, August 13th. Finally, Royal Bank Of Canada dropped their target price on Acadia Healthcare from $43.00 to $28.00 and set an “outperform” rating for the company in a report on Wednesday, August 13th. Eight investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $35.09.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.